ARE THE HIGH SERUM INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS AN USEFUL PROGNOSTIC MARKERS IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA PATIENTS?

by Hava Üsküdar Teke
Published 2014-08-01

Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy

by Tuncer TEMEL, Nur OĞUZ, Şafak Meriç ÖZGENEL, Hava ÜSKÜDAR TEKE, Eren GÜNDÜZ, Ayşegül ÖZAKYOL
Published 2017-09-01

Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report

by Hava Üsküdar Teke, Olga Meltem Akay, Deniz Gören Şahin, Mustafa Karagülle, Eren Gündüz, Neslihan Andıç
Published 2014-01-01

Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration

by Deniz Goren Sahin, Olga Meltem Akay, Hava Üsküdar Teke, Neslihan Andıc, Eren Gunduz, Zafer Gulbas
Published 2013-01-01

Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?

by Hava Üsküdar Teke, Nur Oğuz Davutoğlu, Eren Gündüz, Neslihan Andıç, Cengiz Bal, Beyhan Durak Aras
Published 2017-12-01

del (6)(p22) in de novo Acute Myeloid Leukemia as a Sole Genetic Abnormality

by Neslihan Andıç, Beyhan Durak Aras, Eda Tatlipinar, Sevgi Ozpolat, Hava Uskudar Teke, Eren Gunduz, Meltem Olga Akay
Published 2014-08-01

Impact of trisomy 8 and deletion 17p on leukemic transformation in patients with essential thrombocythemia receiving hydroxyurea treatment

by Neslihan Andıç, Beyhan Durak Aras, Deniz Goren Sahin, Mustafa Karagulle, Hava Uskudar Teke, Eren Gunduz, Meltem Olga Akay
Published 2014-08-01

Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

by Beyhan Durak Aras, Sevgi Isik, Hava Uskudar Teke, Abdulvahap Aslan, Filiz Yavasoglu, Zafer Gulbas, Fatih Demirkan, Hulya Ozen, Oguz Cilingir, Nur Sena Inci, Gulcin Gunden, Tuba Bulduk, Ebru Erzurumluoglu Gokalp, Sinem Kocagil, Sevilhan Artan, Olga Meltem Akay
Published 2021-01-01